Dow Up 0.51% Nasdaq Up 0.24%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
6.52 Down 0.05(0.76%) Nov 21, 4:00PM EST
|After Hours : 6.56 Up 0.04 (0.61%) Nov 21, 6:13PM EST
Prev Close:6.57
Open:6.68
Bid:N/A
Ask:6.60 x 200
1y Target Est:8.28
Beta:0.78
Next Earnings Date:N/A
Day's Range:6.51 - 6.84
52wk Range:3.80 - 9.83
Volume:5,009,142
Avg Vol (3m):6,368,940
Market Cap:1.22B
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIADown 0.76%1.22B
NVSDown 0.30%229.73B
PFEUp 0.03%191.86B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):26.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.10
Quarterly EPS Est (Dec-14) :-0.27
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback